Blood transfusions at home: a new option for terminally ill cancer patients?
NCT ID NCT05509439
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving blood transfusions at home is practical and acceptable for people with advanced blood cancers who have a life expectancy of six months or less. Ten patients were enrolled, and a trained nurse administered transfusions at home following safety guidelines. The goal was to see if patients would agree to the program, complete the transfusions, and report their experiences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Home transfusion program (blood transfusions administered at home by a trained nurse)
What this could lead to
If successful, this could make blood transfusions more convenient and comfortable for terminally ill blood cancer patients, improving their quality of life at home.
What could go wrong
This was a very small study (10 patients) with no control group, so results may not apply to everyone. Home transfusions carry risks like allergic reactions or infections, though the program followed safety guidelines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States